1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Diagnostic Imaging Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Diagnostic Imaging Market Analysis and Forecast, 2022-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. List of Types of Diagnostic Imaging Tests
5.3. Disease Prevalence & Incidence Rate Globally With Key Countries
5.4. COVID-19 Pandemic Impact on Industry
6. Diagnostic Imaging Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017-2031
6.3.1. X-Ray
6.3.2. MRI
6.3.3. Ultrasound
6.3.4. CT
6.3.5. Nuclear Imaging
6.4. Market Attractiveness, by Product
7. Diagnostic Imaging Market Analysis and Forecast, by Application
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Cardiology
7.3.2. Gynecology/Obs
7.3.3. Orthopedics & Musculoskeletal
7.3.4. Radiology
7.3.5. Neurology & Spine
7.3.6. General Imaging
7.3.7. Others
7.4. Market Attractiveness, by Application
8. Global Diagnostic Imaging Market Analysis and Forecast, by End-user
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Diagnostic Centers
8.3.3. Others
8.4. Market Attractiveness, by End-user
9. Global Diagnostic Imaging Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Diagnostic Imaging Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017-2031
10.2.1. X-Ray
10.2.2. MRI
10.2.3. Ultrasound
10.2.4. CT
10.2.5. Nuclear Imaging
10.3. Market Attractiveness, by Product
10.4. Market Value Forecast, by Application, 2017-2031
10.4.1. Cardiology
10.4.2. Gynecology/Obs
10.4.3. Orthopedics & Musculoskeletal
10.4.4. Radiology
10.4.5. Neurology & Spine
10.4.6. General Imaging
10.4.7. Others
10.5. Market Attractiveness, by Application
10.6. Market Value Forecast, by End-user, 2017-2031
10.6.1. Hospitals
10.6.2. Diagnostic Centers
10.6.3. Others
10.7. Market Attractiveness, by End-user
10.8. Market Value Forecast, by Country, 2022-2031
10.8.1. U.S.
10.8.2. Canada
10.9. Market Attractiveness Analysis
10.9.1. By Product
10.9.2. By Application
10.9.3. By End-user
10.9.4. By Country
11. Europe Diagnostic Imaging Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017-2031
11.2.1. X-Ray
11.2.2. MRI
11.2.3. Ultrasound
11.2.4. CT
11.2.5. Nuclear Imaging
11.3. Market Attractiveness, by Product
11.4. Market Value Forecast, by Application, 2017-2031
11.4.1. Cardiology
11.4.2. Gynecology/Obs
11.4.3. Orthopedics & Musculoskeletal
11.4.4. Radiology
11.4.5. Neurology & Spine
11.4.6. General Imaging
11.4.7. Others
11.5. Market Attractiveness, by Application
11.6. Market Value Forecast, by End-user, 2017-2031
11.6.1. Hospitals
11.6.2. Diagnostic Centers
11.6.3. Others
11.7. Market Attractiveness, by End-user
11.8. Market Value Forecast, by Country/Sub-region, 2022-2031
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Rest of Europe
11.9. Market Attractiveness Analysis
11.9.1. By Product
11.9.2. By Application
11.9.3. By End-user
11.9.4. By Country/Sub-region
12. Asia Pacific Diagnostic Imaging Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017-2031
12.2.1. X-Ray
12.2.2. MRI
12.2.3. Ultrasound
12.2.4. CT
12.2.5. Nuclear Imaging
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Application, 2017-2031
12.4.1. Cardiology
12.4.2. Gynecology/Obs
12.4.3. Orthopedics & Musculoskeletal
12.4.4. Radiology
12.4.5. Neurology & Spine
12.4.6. General Imaging
12.4.7. Others
12.5. Market Attractiveness, by Application
12.6. Market Value Forecast, by End-user, 2017-2031
12.6.1. Hospitals
12.6.2. Diagnostic Centers
12.6.3. Others
12.7. Market Attractiveness, by End-user
12.8. Market Value Forecast, by Country/Sub-region, 2017-2031
12.8.1. China
12.8.2. Japan
12.8.3. India
12.8.4. Australia & New Zealand
12.8.5. Rest of Asia Pacific
12.9. Market Attractiveness Analysis
12.9.1. By Product
12.9.2. By Application
12.9.3. By End-user
12.9.4. By Country/Sub-region
13. Latin America Diagnostic Imaging Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017-2031
13.2.1. X-Ray
13.2.2. MRI
13.2.3. Ultrasound
13.2.4. CT
13.2.5. Nuclear Imaging
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Application, 2017-2031
13.4.1. Cardiology
13.4.2. Gynecology/Obs
13.4.3. Orthopedics & Musculoskeletal
13.4.4. Radiology
13.4.5. Neurology & Spine
13.4.6. General Imaging
13.4.7. Others
13.5. Market Attractiveness, by Application
13.6. Market Value Forecast, by End-user, 2017-2031
13.6.1. Hospitals
13.6.2. Diagnostic Centers
13.6.3. Others
13.7. Market Attractiveness, by End-user
13.8. Market Value Forecast, by Country/Sub-region, 2017-2031
13.8.1. Brazil
13.8.2. Mexico
13.8.3. Rest of Latin America
13.9. Market Attractiveness Analysis
13.9.1. By Product
13.9.2. By Application
13.9.3. By End-user
13.9.4. By Country/Sub-region
14. Middle East & Africa Diagnostic Imaging Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017-2031
14.2.1. X-Ray
14.2.2. MRI
14.2.3. Ultrasound
14.2.4. CT
14.2.5. Nuclear Imaging
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Application, 2017-2031
14.4.1. Cardiology
14.4.2. Gynecology/Obs
14.4.3. Orthopedics & Musculoskeletal
14.4.4. Radiology
14.4.5. Neurology & Spine
14.4.6. General Imaging
14.4.7. Others
14.5. Market Attractiveness, by Application
14.6. Market Value Forecast, by End-user, 2017-2031
14.6.1. Hospitals
14.6.2. Diagnostic Centers
14.6.3. Others
14.7. Market Attractiveness, by End-user
14.8. Market Value Forecast, by Country/Sub-region, 2017-2031
14.8.1. GCC Countries
14.8.2. South Africa
14.8.3. Rest of Middle East & Africa
14.9. Market Attractiveness Analysis
14.9.1. By Product
14.9.2. By Application
14.9.3. By End-user
14.9.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. GE Healthcare
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Koninklijke Philips N.V.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Hologic, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Siemens Healthcare GmbH
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Fujifilm Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Toshiba Medical Systems Corporation
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Shimadzu Corporation
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Carestream Health, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Hitachi Ltd.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Samsung Medison
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer